help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2003
Endocrinology, doi:10.1210/en.2003-0480
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/9/3811    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteman, E. L.
Right arrow Articles by Birnbaum, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteman, E. L.
Right arrow Articles by Birnbaum, M. J.

Submitted on April 17, 2003
Accepted on May 20, 2003

PDGF Stimulates Glucose Transport in 3T3-L1 Adipocytes Overexpressing PDGF Receptor by a Pathway Independent of Insulin Receptor Substrates

Eileen L. Whiteman1, Janine J. Chen1, and Morris J. Birnbaum1*

1 Howard Hughes Medical Institute, Cox Institute, Cell and Molecular Biology Graduate Group, and the Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104; ELW is supported by a Howard Hughes Pre-Doctoral Fellowship for the Biological Sciences.; JJC participated in the Howard Hughes Undergraduate Summer Research Program.

* To whom correspondence should be addressed. E-mail: birnbaum{at}mail.med.upenn.edu.

Insulin is unique among growth factors and hormones in its ability to control metabolic functions such as the stimulation of glucose uptake and glucose transporter (GLUT4) translocation in physiological target tissues, such as muscle and adipose cells. Nonetheless, the mechanisms underlying this specificity have remained incompletely understood, particularly in view of the ability of some growth factors to mimic insulin-dependent early signaling events. In this study, we have probed the basis of insulin specificity by overexpressing in hormone-responsive 3T3-L1 adipocytes wild-type platelet-derived growth factor receptor {beta} (PDGFR-{beta}) and selected, informative mutant receptor proteins. We show that such adipocytes overexpressing wild-type PDGFR upon exposure to cognate growth factor activate glucose transport, GLUT4 translocation, and the serine-threonine protein kinase Akt/Protein kinase B to a degree comparable to that produced in response to insulin. In addition, PDGF elicits the robust generation of PIP3 in vivo in PDGFR-overexpressing 3T3-L1 adipocytes. Expression of PDGFR-{beta} mutant proteins demonstrates that these responses require the presence of an intact PI3-Kinase binding site on the overexpressed PDGF receptor. Furthermore, PDGF stimulates these effects independent of insulin receptor substrate-1 (IRS-1) or insulin receptor substrate-2 (IRS-2) tyrosine phosphorylation or docking to activated PI3-Kinase. These data demonstrate that 1) the basis of insulin-specific glucose transport in cultured adipocytes is the low level of receptors for other growth factors and 2) in the presence of adequate receptors, PDGF is fully capable of activating glucose transport in a manner requiring PI3-Kinase and subsequent PIP3 accumulation but independent of insulin, insulin receptor, and IRS proteins.


Key words: Insulin • Glucose Transport • Adipocytes • PI3-Kinase • PDGF • Akt • Protein Kinase B • Insulin Receptor Substrate







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society